Do the revised Guidelines or the Supplemental Guidance recommend development of specific data on childrens risk?
Both the Guidelines and the Supplemental Guidance discuss general ways of proceeding when there are no early-life studies on a potential carcinogen. Nonetheless, there may be cases where these general approaches may not adequately reflect differential risks to children. As in all cases, specific data on the effects of early-life exposures is valuable in improving the assessment.
